3-MeO-PCP

3-Methoxyphencyclidine (3-MeO-PCP): Chemical Properties, Pharmacology, and Forensic Research Applications

Introduction

3-Methoxyphencyclidine (3-MeO-PCP) is a synthetic arylcyclohexylamine compound structurally related to phencyclidine (PCP). It is primarily discussed in forensic toxicology, analytical chemistry, and neuropharmacology literature due to its activity as an NMDA receptor antagonist and its appearance in designer drug monitoring programs.

This article provides an educational overview of the compound's chemical properties, pharmacology, analytical applications, and regulatory considerations.

Informational: Chemical Identity and Properties

Chemical Information

PropertyValueChemical Name1-(1-(3-Methoxyphenyl)cyclohexyl)piperidineCommon Name3-MeO-PCPCAS Number72242-03-6Molecular FormulaC18H27NOMolecular Weight273.4 g/molChemical ClassArylcyclohexylamineAppearanceWhite crystalline solid (hydrochloride salt reported)Primary Research AreasNeuropharmacology, toxicology, analytical chemistryThe compound was originally synthesized during investigations into structure-activity relationships among PCP analogues and later became known through forensic monitoring of novel psychoactive substances.

Pharmacology and Mechanism of Action

NMDA Receptor Activity

Research indicates that 3-MeO-PCP functions primarily as a non-competitive NMDA receptor antagonist. Binding studies have demonstrated high affinity for the NMDA receptor's dizocilpine (MK-801) binding site.

Additional Receptor Interactions

Published receptor-binding studies suggest measurable interaction with:

• Serotonin transporter (SERT)
• Sigma-1 receptor

Studies cited in the uploaded document report that the compound does not exhibit significant opioid receptor activity and is not considered a dopamine reuptake inhibitor.

Neuropharmacology Research

Researchers have used 3-MeO-PCP to examine:

• Glutamatergic signaling pathways
• NMDA receptor function
• Structure-activity relationships (SAR)
• Dissociative pharmacology models

Why Exact Analytical Standards Matter

Positional Isomer Identification

One of the most important forensic challenges with 3-MeO-PCP is distinguishing it from related compounds, such as 4-MeO-PCP.

Although these compounds may share similar molecular masses, laboratories rely on:

• LC-MS/MS
• LC-TOF-MS
• Retention time analysis
• Fragmentation pattern comparison

to accurately distinguish between positional isomers.

Analytical Validation

Certified reference standards are used to:

• Validate laboratory methods
• Establish retention times
• Verify mass spectrometry results
• Improve forensic accuracy

These practices help ensure reliable identification in toxicology and forensic investigations.

Commercial: Research and Laboratory Applications

Forensic Toxicology

3-MeO-PCP reference materials may be used for:

• Drug screening validation
• Postmortem toxicology analysis
• Clinical toxicology investigations
• Emerging substance surveillance

Neuropharmacology Research

The compound is frequently discussed in:

• Receptor binding studies
• Neurochemical research
• Drug-discovery investigations
• Structure-activity relationship projects

Analytical Chemistry

Laboratories may employ validated standards when developing:

• HPLC methods
• LC-MS/MS protocols
• GC-MS screening procedures
• Toxicological confirmation assays

Transactional: Compliance and Regulatory Considerations

Regulatory Status

The legal status of 3-MeO-PCP varies internationally.

According to the uploaded material, restrictions or prohibitions have been reported in several jurisdictions, including:

• United Kingdom
• Canada
• Sweden
• Czech Republic
• Chile

While legal treatment may differ in other regions, researchers must consult current local regulations before handling or studying the compound.

Documentation Requirements

Research institutions commonly require:

• Certificate of Analysis (COA)
• Safety Data Sheet (SDS)
• Institutional authorization
• Controlled substance compliance procedures

Safety and Toxicology Considerations

Published reports have associated 3-MeO-PCP exposure with serious adverse effects, including:

• Confusion
• Disorientation
• Hypertension
• Tachycardia
• Psychosis in some reported cases

Fatal intoxications have also been documented in forensic literature. Because of these risks, the compound should be discussed and handled only within lawful scientific, analytical, or educational settings.

Conclusion

3-Methoxyphencyclidine (3-MeO-PCP) remains an important subject in forensic toxicology, analytical chemistry, and neuropharmacological research. Its high affinity for NMDA receptors, unique receptor-binding profile, and relevance in emerging substance monitoring make it valuable for scientific investigation. Accurate analytical standards, regulatory compliance, and rigorous laboratory procedures are essential for responsible research and forensic identification.

 3-MeO-PCP, 3-Methoxyphencyclidine, arylcyclohexylamine research, NMDA receptor antagonist, forensic toxicology, analytical reference standard, LC-MS/MS validation, neuropharmacology research, structure activity relationship studies, dissociative compound analysis.